Search Results - "Monza, D"

Refine Results
  1. 1

    Whole body cholesterol metabolism is impaired in Huntington's disease by Leoni, V., Mariotti, C., Nanetti, L., Salvatore, E., Squitieri, F., Bentivoglio, A.R., Bandettini del Poggio, M., Piacentini, S., Monza, D., Valenza, M., Cattaneo, E., Di Donato, S.

    Published in Neuroscience letters (02-05-2011)
    “…► Impaired cholesterol biosynthesis in rodent models of Huntington Disease (HD). ► Reduced brain cholesterol turnover in HD patients as plasma…”
    Get full text
    Journal Article
  2. 2

    Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy by SOLIVERI, P, MONZA, D, PARIDI, D, RADICE, D, GRISOLI, M, TESTA, D, SAVOIARDO, M, GIROTTI, F

    Published in Neurology (11-08-1999)
    “…To identify cognitive and MRI features important for the clinical diagnosis of corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP); these…”
    Get full text
    Journal Article
  3. 3

    Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy by Soliveri, Paola, Monza, Daniela, Paridi, Dominga, Carella, Francesco, Genitrini, Silvia, Testa, Daniela, Girotti, Floriano

    “…OBJECTIVES Impairment of executive function is frequent in Parkinson's disease (PD), striatonigral degeneration-type multisystem atrophy (SND), and progressive…”
    Get full text
    Journal Article
  4. 4

    Affective symptoms in multiple system atrophy and Parkinson’s disease: response to levodopa therapy by Fetoni, V, Soliveri, P, Monza, D, Testa, D, Girotti, F

    “…The objective was to determine the extent to which psychiatric disturbances (especially mood disorders) generally considered poor prognostic factors, are…”
    Get full text
    Journal Article
  5. 5

    Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy by Testa, D, Monza, D, Ferrarini, M, Soliveri, P, Girotti, F, Filippini, G

    Published in Neurological sciences (01-06-2001)
    “…In order to identify early clinical features and survival predictors of supranuclear palsy (PSP) and multiple system atrophy (MSA), we compared the disease…”
    Get full text
    Journal Article
  6. 6

    Neurophysiological features in relation to clinical signs in clinically diagnosed corticobasal degeneration by Monza, D, Ciano, C, Scaioli, V, Soliveri, P, Carella, F, Avanzini, G, Girotti, F

    Published in Neurological sciences (01-04-2003)
    “…We investigated the association between clinical and neurophysiological characteristics in patients with a clinical diagnosis of probable corticobasal…”
    Get full text
    Journal Article
  7. 7

    Cognitive and psychiatric characterization of patients with Huntington's disease and their at-risk relatives by Soliveri, P, Monza, D, Piacentini, S, Paridi, D, Nespolo, C, Gellera, C, Mariotti, C, Albanese, A, Girotti, F

    Published in Neurological sciences (01-09-2002)
    “…We examined cognitive and psychiatric disturbances in patients with Huntington's disease (HD) in comparison to at-risk asymptomatic subjects. Cognitive and…”
    Get full text
    Journal Article
  8. 8

    A study of arm movements in Huntington's disease under visually controlled and blindfolded conditions by Carella, F, Bressanelli, M, Piacentini, S, Soliveri, P, Geminiani, G, Monza, D, Albanese, A, Girotti, F

    Published in Neurological sciences (01-02-2003)
    “…The so-called bradykinesia of Huntington's disease (HD) seems not due to reduced movement speed alone but may also be task-dependent. We therefore investigated…”
    Get full text
    Journal Article
  9. 9

    Progression of motor and cognitive impairment in Parkinson's disease by PALAZZINI, E, SOLIVERI, P, FILIPPINI, G, FETONI, V, ZAPPACOSTA, B, SCIGLIANO, G, MONZA, D, CARACENI, T, GIROTTI, F

    Published in Journal of neurology (01-08-1995)
    “…We performed a longitudinal study (mean follow-up 86.7 months) to evaluate motor and mental deterioration in patients with Parkinson's disease. Of the original…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Identification of symbol digit modality test score extremes in Huntington's disease by Braisch, Ulrike, Muche, Rainer, Rothenbacher, Dietrich, Landwehrmeyer, Georg Bernhard, Long, Jeffrey D., Orth, Michael

    “…Studying individuals with extreme phenotypes could facilitate the understanding of disease modification by genetic or environmental factors. Our aim was to…”
    Get full text
    Journal Article
  12. 12

    Variations in axial, proximal, and distal motor response to L-dopa in multisystem atrophy and Parkinson's disease by Fetoni, V, Genitrini, S, Monza, D, Soliveri, P, Testa, D, Caraceni, T, Girotti, F

    Published in Clinical neuropharmacology (01-06-1997)
    “…The purpose of this study was to quantitatively compare the motor response to L-dopa in Parkinson's disease (PD) and striatonigral-type multisystem atrophy…”
    Get more information
    Journal Article
  13. 13

    Cognitive dysfunction and impaired organization of complex motility in degenerative parkinsonian syndromes by Monza, D, Soliveri, P, Radice, D, Fetoni, V, Testa, D, Caffarra, P, Caraceni, T, Girotti, F

    Published in Archives of neurology (Chicago) (01-03-1998)
    “…A frontostriatal pattern of cognitive decline, consisting of a frontal lobe-like syndrome without genuine cortical defects such as amnesia, apraxia, aphasia,…”
    Get more information
    Journal Article
  14. 14

    G07 Differences between Huntington's disease and spinocerebellar ataxia types 1 and 2 on cognitive and behavioural profile by Soliveri, P, Mariotti, C, Paridi, D, Monza, D, Tomasello, C, Panzeri, M, Taroni, F, Albanese, A, Girotti, F

    “…Background Huntington's disease (HD) patients show progressive, mostly frontal-striatal-type, cognitive deterioration, and heterogeneous psychiatric symptoms…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease by Zappacosta, B, Monza, D, Meoni, C, Austoni, L, Soliveri, P, Gellera, C, Alberti, R, Mantero, M, Penati, G, Caraceni, T, Girotti, F

    Published in Archives of neurology (Chicago) (01-06-1996)
    “…To investigate the hypothesis that psychiatric disturbances in Huntington's disease are related to degree of cognitive or motor compromise and to determine…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Hemiballism in a patient with probable multiple system atrophy by Testa, D, Grisoli, M, Monza, D, Girotti, F

    Published in Functional neurology (01-01-1997)
    “…We report a patient with long-standing asymmetrical parkinsonism, cerebellar ataxia and dysautonomia, suggestive of multiple system atrophy (MSA). However, the…”
    Get more information
    Journal Article
  19. 19

    Combined poly(isobutylcyanoacrylate) and cyclodextrins nanoparticles for enhancing the encapsulation of lipophilic drugs by MONZA DA SILVEIRA, A, PONCHEL, G, PUISIEUX, F, DUCHENE, D

    Published in Pharmaceutical research (01-07-1998)
    “…The aim of this study was to prepare and characterize nanoparticulate systems constituted of poly(isobutylcyanoacrylate) and cyclodextrins and intended for…”
    Get full text
    Journal Article
  20. 20

    A case of dementia parkinsonism resembling progressive supranuclear palsy due to mutation in the tau protein gene by Soliveri, Paola, Rossi, Giacomina, Monza, Daniela, Tagliavini, Fabrizio, Piacentini, Sylvie, Albanese, Alberto, Bugiani, Orso, Girotti, Floriano

    Published in Archives of neurology (Chicago) (01-10-2003)
    “…Few cases of frontotemporal dementia parkinsonism (FTDP-17) have been described in the literature. To our knowledge, this is the first Italian case. To report…”
    Get more information
    Journal Article